Bio Plus Co., Ltd Stock

Equities

A099430

KR7099430001

Pharmaceuticals

End-of-day quote Korea S.E. 18:00:00 2024-07-18 EDT 5-day change 1st Jan Change
6,420 KRW +4.90% Intraday chart for Bio Plus Co., Ltd +5.07% -6.55%

Financials

Sales 2022 56.72B 40.78M 56.04M Sales 2023 65.04B 46.77M 64.26M Capitalization 393B 282M 388M
Net income 2022 21.14B 15.2M 20.88M Net income 2023 25.58B 18.39M 25.27M EV / Sales 2022 5.82 x
Net cash position 2022 72.18B 51.9M 71.32M Net cash position 2023 55.74B 40.08M 55.07M EV / Sales 2023 5.18 x
P/E ratio 2022
18.8 x
P/E ratio 2023
15.9 x
Employees 84
Yield 2022
1.01%
Yield 2023
1.02%
Free-Float 68.01%
More Fundamentals * Estimated data
Dynamic Chart
1 day+4.90%
1 week+5.07%
Current month+15.05%
1 month+23.94%
3 months-1.23%
6 months-5.03%
Current year-6.55%
More quotes
1 week
5 750.00
Extreme 5750
6 520.00
1 month
4 875.00
Extreme 4875
6 730.00
Current year
4 250.00
Extreme 4250
7 450.00
1 year
4 250.00
Extreme 4250
9 090.00
3 years
4 250.00
Extreme 4250
10 750.00
5 years
4 250.00
Extreme 4250
10 750.00
10 years
4 250.00
Extreme 4250
10 750.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 67 13-02-28
Chief Tech/Sci/R&D Officer 57 05-10-31
Director/Board Member 52 18-12-31
Members of the board TitleAgeSince
Chief Executive Officer 67 13-02-28
Chief Tech/Sci/R&D Officer 57 05-10-31
Director/Board Member 65 18-10-31
More insiders
Date Price Change Volume
24-07-18 6,420 +4.90% 1 024 201
24-07-18 6,120 -1.13% 459,873
24-07-17 6,190 -1.28% 570,459
24-07-16 6,270 +7.73% 994,570
24-07-15 5,820 -3.64% 534,959

End-of-day quote Korea S.E., July 18, 2024

More quotes
BioPlus Co Ltd is a Korea-based company principally engaged in the medical device business. The Company is engaged in the production and sale of biomaterials for tissue restoration used for temporary improvement of facial wrinkles, namely hyaluronic acid fillers. In addition, the Company is engaged in the production and sale of anti-adhesion agents that reduce the formation of adhesions in surgical areas, biomaterials for joint tissue repair, and other products.
More about the company

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A099430 Stock